Published in Biomed Res Int on June 13, 2013
Inhibition of host immune response in colorectal cancer: human leukocyte antigen-G and beyond. World J Gastroenterol (2014) 0.78
Immunomodulatory properties of HLA-G in infectious diseases. J Immunol Res (2014) 0.78
Evolution of the levels of human leukocyte antigen G (HLA-G) in Beninese infant during the first year of life in a malaria endemic area: using latent class analysis. Malar J (2016) 0.76
Soluble human leukocyte antigen -G during pregnancy and infancy in Benin: Mother/child resemblance and association with the risk of malaria infection and low birth weight. PLoS One (2017) 0.75
Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections? Front Immunol (2017) 0.75
A whole-genome association study of major determinants for host control of HIV-1. Science (2007) 15.19
HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science (2004) 8.22
Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med (1996) 7.08
HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature (1998) 6.94
The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity (1999) 6.80
Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat Med (2007) 6.01
Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS (2003) 5.85
lncRNAdb: a reference database for long noncoding RNAs. Nucleic Acids Res (2010) 4.49
HIV-1: fifteen proteins and an RNA. Annu Rev Biochem (1998) 4.33
Small regulatory RNAs in mammals. Hum Mol Genet (2005) 4.15
Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity (2005) 3.70
Common genetic variation and the control of HIV-1 in humans. PLoS Genet (2009) 3.68
Influence of HLA-C expression level on HIV control. Science (2013) 3.27
The biogenesis and function of PIWI proteins and piRNAs: progress and prospect. Annu Rev Cell Dev Biol (2009) 3.21
The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes. EMBO J (1998) 3.17
HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet (2009) 3.03
Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood (2008) 2.96
HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes. Nat Cell Biol (2000) 2.95
HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc Natl Acad Sci U S A (1993) 2.91
HIV-1 auxiliary proteins: making connections in a dying cell. Cell (1998) 2.68
Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature (2011) 2.36
HIV-1 encoded candidate micro-RNAs and their cellular targets. Retrovirology (2004) 2.23
Chemokine receptors: keys to AIDS pathogenesis? Cell (1998) 2.15
HIV-1 nef suppression by virally encoded microRNA. Retrovirology (2004) 2.05
Allele and locus-specific differences in cell surface expression and the association of HLA class I heavy chain with beta 2-microglobulin: differential effects of inhibition of glycosylation on class I subunit association. Eur J Immunol (1988) 2.03
MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals. Retrovirology (2008) 1.96
miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1. PLoS Pathog (2009) 1.94
Analysis of the interaction of primate retroviruses with the human RNA interference machinery. J Virol (2007) 1.93
Transcriptional and posttranscriptional regulation of HIV-1 gene expression. Cold Spring Harb Perspect Med (2012) 1.88
Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology (2008) 1.87
Viral mechanisms of immune evasion. Trends Microbiol (2000) 1.85
Pyrosequencing of small non-coding RNAs in HIV-1 infected cells: evidence for the processing of a viral-cellular double-stranded RNA hybrid. Nucleic Acids Res (2009) 1.69
Species-specific evolution of MHC class I genes in the higher primates. Immunol Rev (2001) 1.67
Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients. Retrovirology (2012) 1.62
Molecular structure of human histocompatibility antigens: the HLA-C series. Eur J Immunol (1977) 1.61
Regulation of human immunodeficiency virus 1 transcription by nef microRNA. J Gen Virol (2005) 1.46
IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol (1999) 1.46
The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci U S A (1997) 1.44
Distinct trafficking pathways mediate Nef-induced and clathrin-dependent major histocompatibility complex class I down-regulation. J Virol (2000) 1.44
HIV-1 Tat RNA silencing suppressor activity is conserved across kingdoms and counteracts translational repression of HIV-1. Proc Natl Acad Sci U S A (2009) 1.39
Naming 'junk': human non-protein coding RNA (ncRNA) gene nomenclature. Hum Genomics (2011) 1.39
Interplay between HIV-1 infection and host microRNAs. Nucleic Acids Res (2011) 1.36
HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology (2009) 1.35
Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction. J Immunol (1998) 1.34
Nef-mediated disruption of HLA-A2 transport to the cell surface in T cells. J Virol (2003) 1.32
In silico analysis of microRNAS targeting the HLA-G 3' untranslated region alleles and haplotypes. Hum Immunol (2009) 1.27
Direct binding of human immunodeficiency virus type 1 Nef to the major histocompatibility complex class I (MHC-I) cytoplasmic tail disrupts MHC-I trafficking. J Virol (2002) 1.26
Dual role of TRBP in HIV replication and RNA interference: viral diversion of a cellular pathway or evasion from antiviral immunity? Retrovirology (2005) 1.21
Reappraisal of the relationship between the HIV-1-protective single-nucleotide polymorphism 35 kilobases upstream of the HLA-C gene and surface HLA-C expression. J Virol (2011) 1.21
In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms. MBio (2013) 1.18
Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol (2000) 1.18
Viral RNA silencing suppressors (RSS): novel strategy of viruses to ablate the host RNA interference (RNAi) defense system. Virus Res (2010) 1.17
HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells. Antivir Ther (2005) 1.16
Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS (2002) 1.11
miRNA profiles of monocyte-lineage cells are consistent with complicated roles in HIV-1 restriction. Viruses (2012) 1.09
MiRNA-mediated control of HLA-G expression and function. PLoS One (2012) 1.08
Genetic susceptibility to malaria and other infectious diseases: from the MHC to the whole genome. Parasitology (1996) 1.08
T-cell induced pathogenesis in HIV: bystander effects and latent infection. Proc Biol Sci (1999) 1.07
Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol (2000) 1.03
MHC class I alleles and their exploration of the antigen-processing machinery. Immunol Rev (2005) 1.02
The HLA-B/-C haplotype block contains major determinants for host control of HIV. Genes Immun (2009) 1.00
Overexpression of miR-152 leads to reduced expression of human leukocyte antigen-G and increased natural killer cell mediated cytolysis in JEG-3 cells. Am J Obstet Gynecol (2010) 1.00
Functionally active HLA-G polymorphisms are associated with the risk of heterosexual HIV-1 infection in African women. AIDS (2004) 0.99
Tat RNA silencing suppressor activity contributes to perturbation of lymphocyte miRNA by HIV-1. Retrovirology (2011) 0.99
Counteraction of HLA-C-mediated immune control of HIV-1 by Nef. J Virol (2010) 0.99
miR-132 enhances HIV-1 replication. Virology (2013) 0.98
HLA-G and HLA-E: fundamental and Pathophysiological aspects. Immunol Today (2000) 0.96
Detection of HLA-G5 secreting cells. Hum Immunol (2003) 0.96
The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G. Diabetes (2006) 0.96
Natural killer cell responses to HIV-1 peptides are associated with more activating KIR genes and HLA-C genes of the C1 allotype. J Acquir Immune Defic Syndr (2011) 0.93
Assembly and export of MHC class I peptide ligands. Curr Opin Immunol (2003) 0.92
MicroRNA-mediated restriction of HIV-1 in resting CD4+ T cells and monocytes. Viruses (2012) 0.90
Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen (HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis. Clin Exp Immunol (2007) 0.89
gp41 envelope protein of human immunodeficiency virus induces interleukin (IL)-10 in monocytes, but not in B, T, or NK cells, leading to reduced IL-2 and interferon-gamma production. J Infect Dis (1998) 0.87
Does the presence of anti-HIV miRNAs in monocytes explain their resistance to HIV-1 infection? Blood (2009) 0.87
Persistence of high levels of blood soluble human leukocyte antigen-G is associated with rapid progression of HIV infection. AIDS (2009) 0.85
HLA-C revisited. Ten years of change. Immunol Res (1997) 0.84
Human immunodeficiency virus 1 downregulates cell surface expression of the non-classical major histocompatibility class I molecule HLA-G1. J Gen Virol (2004) 0.83
A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected Thais. PLoS One (2011) 0.83
HLA-G expression in cancers: potential role in diagnosis, prognosis and therapy. Endocr Metab Immune Disord Drug Targets (2011) 0.83
The short cytoplasmic tail of HLA-G determines its resistance to HIV-1 Nef-mediated cell surface downregulation. Hum Immunol (2004) 0.81
Induction of HLA-G-restricted human cytomegalovirus pp65 (UL83)-specific cytotoxic T lymphocytes in HLA-G transgenic mice. J Gen Virol (2003) 0.81
Associations of human leukocyte antigen-G with resistance and susceptibility to HIV-1 infection in the Pumwani sex worker cohort. AIDS (2013) 0.78
HLA-G*0105N allele is associated with augmented risk for HIV infection in white female patients. AIDS (2010) 0.78
HLA-G 3' untranslated region 14-base pair deletion: association with poor survival in an HIV-1-infected Zimbabwean population. J Infect Dis (2012) 0.78
HLA-G*0105N null allele encodes functional HLA-G isoforms. Biol Reprod (2005) 0.77
Lack of MHC-G4 and soluble (G5, G6) isoforms in the higher primates, Pongidae. Hum Immunol (2000) 0.77
HLA-G expression in acute lymphoblastic leukemia: a significant prognostic tumor biomarker. Med Oncol (2013) 0.77
A single-nucleotide polymorphism in the human beta-defensin 1 gene is associated with HIV-1 infection in Italian children. AIDS (2004) 1.59
High polymorphism of the MBL2 gene in patients with atopic dermatitis. Ann Allergy Asthma Immunol (2010) 1.47
Secreted protein acidic and rich in cysteine (SPARC) gene polymorphism association with hepatocellular carcinoma in Italian patients. J Gastroenterol Hepatol (2009) 1.42
"Hyper-IgD syndrome" or "mevalonate kinase deficiency": an old syndrome needing a new name? Rheumatol Int (2013) 1.40
Beta defensin-1 gene (DEFB1) polymorphisms are not associated with atopic dermatitis in children and adolescents from northeast Brazil (Recife, Pernambuco). Int J Dermatol (2010) 1.39
DEFB1 gene polymorphisms and increased risk of HIV-1 infection in Brazilian children. AIDS (2006) 1.22
MBL2 gene polymorphisms protect against development of thrombocytopenia associated with severe dengue phenotype. Hum Immunol (2008) 1.14
F402L variant in NLRP12 in subjects with undiagnosed periodic fevers and in healthy controls. Clin Exp Rheumatol (2014) 1.12
The missense variation Q705K in CIAS1/NALP3/NLRP3 gene and an NLRP1 haplotype are associated with celiac disease. Am J Gastroenterol (2011) 1.10
Polimorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus. Autoimmunity (2012) 1.09
Defect in mevalonate pathway induces pyroptosis in Raw 264.7 murine monocytes. Apoptosis (2011) 1.07
Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity. J Biol Chem (2006) 1.07
Family history in early-onset inflammatory bowel disease. J Gastroenterol (2012) 1.04
Human beta-defensin 2 induces a vigorous cytokine response in peripheral blood mononuclear cells. Antimicrob Agents Chemother (2006) 1.03
Mevalonate kinase deficiency and neuroinflammation: balance between apoptosis and pyroptosis. Int J Mol Sci (2013) 1.00
Effects of positively selected sequence variations in human and Macaca fascicularis beta-defensins 2 on antimicrobial activity. Antimicrob Agents Chemother (2004) 0.99
HIV-1 induces NALP3-inflammasome expression and interleukin-1β secretion in dendritic cells from healthy individuals but not from HIV-positive patients. AIDS (2012) 0.99
A 3'UTR SNP in NLRP3 gene is associated with susceptibility to HIV-1 infection. J Acquir Immune Defic Syndr (2010) 0.98
Beta-defensin 1 gene variability among non-human primates. Immunogenetics (2002) 0.98
IL-18 gene promoter polymorphism is involved in HIV-1 infection in a Brazilian pediatric population. Immunogenetics (2006) 0.97
Lovastatin-induced apoptosis is modulated by geranylgeraniol in a neuroblastoma cell line. Int J Dev Neurosci (2012) 0.97
A new mutation in two siblings with cystinosis presenting with Bartter syndrome. Pediatr Nephrol (2004) 0.97
Natural isoprenoids inhibit LPS-induced-production of cytokines and nitric oxide in aminobisphosphonate-treated monocytes. Int Immunopharmacol (2010) 0.97
Diagnostics and therapeutic insights in a severe case of mevalonate kinase deficiency. Pediatrics (2007) 0.96
DEFB-1 genetic polymorphism screening in HIV-1 positive pregnant women and their children. J Matern Fetal Neonatal Med (2006) 0.94
A study of host defence peptide beta-defensin 3 in primates. Biochem J (2003) 0.94
Evaluation of a nested-PCR for mycobacterium tuberculosis detection in blood and urine samples. Braz J Microbiol (2011) 0.93
Overview on plant antimicrobial peptides. Curr Protein Pept Sci (2010) 0.92
Effects of maturation on RNA transcription and protein expression of four MRP genes in human placenta and in BeWo cells. Biochem Biophys Res Commun (2003) 0.92
Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models. BMC Biotechnol (2007) 0.92
MBL2 polymorphisms screening in a regional Italian CF Center. J Cyst Fibros (2005) 0.92
Geraniol rescues inflammation in cellular and animal models of mevalonate kinase deficiency. In Vivo (2011) 0.91
NALP1/NLRP1 genetic variants are associated with Alzheimer disease. Alzheimer Dis Assoc Disord (2012) 0.91
Polymorphisms in inflammasome' genes and susceptibility to HIV-1 infection. J Acquir Immune Defic Syndr (2012) 0.91
Polymorphisms in STK17A gene are associated with systemic lupus erythematosus and its clinical manifestations. Gene (2013) 0.89
Pin1 promoter polymorphisms in hepatocellular carcinoma patients. Gastroenterology (2007) 0.89
The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency. Pediatr Res (2011) 0.89
Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: in vitro and in vivo approaches. Pharmacol Res (2010) 0.88
Copy number variation of defensin genes and HIV infection in Brazilian children. J Acquir Immune Defic Syndr (2009) 0.88
Prevalence of autoimmune thyroid disease and thyroid dysfunction in young Brazilian patients with type 1 diabetes. Pediatr Diabetes (2008) 0.88
Solid-phase synthesis, characterization, and antibacterial activities of metallocene-peptide bioconjugates. ChemMedChem (2006) 0.88
Polymorphisms in innate immunity genes and patients response to dendritic cell-based HIV immuno-treatment. Vaccine (2010) 0.87
The inhibition of mevalonate pathway induces upregulation of NALP3 expression: new insight in the pathogenesis of mevalonate kinase deficiency. Eur J Hum Genet (2010) 0.87
Transcriptional effect of DEFB1 gene 5' untranslated region polymorphisms. Cancer Res (2007) 0.87
Genetic variant of C1GalT1 contributes to the susceptibility to IgA nephropathy. J Nephrol (2009) 0.86
Association between HLA-G 3'UTR 14-bp polymorphism and HIV vertical transmission in Brazilian children. AIDS (2009) 0.86
A common genetic background could explain early-onset Crohn's disease. Med Hypotheses (2012) 0.86
Anti-amnesic and neuroprotective actions of the sigma-1 receptor agonist (-)-MR22 in rats with selective cholinergic lesion and amyloid infusion. J Alzheimers Dis (2011) 0.85
Mevalonate kinase deficiency: disclosing the role of mevalonate pathway modulation in inflammation. Curr Pharm Des (2012) 0.85
Mouse model of mevalonate kinase deficiency: comparison of cytokine and chemokine profile with that of human patients. Pediatr Res (2013) 0.85
New variants of E6 and E7 oncogenes of human papillomavirus type 31 identified in Northeastern Brazil. Gynecol Oncol (2011) 0.85
MBL2 gene polymorphisms and susceptibility to tuberculosis in a northeastern Brazilian population. Infect Genet Evol (2013) 0.85
NLRP1 polymorphisms in patients with asbestos-associated mesothelioma. Infect Agent Cancer (2012) 0.85
Mannose binding lectin gene polymorphisms are associated with type 1 diabetes in Brazilian children and adolescents. Hum Immunol (2007) 0.84
Identification of plant protein kinases in response to abiotic and biotic stresses using SuperSAGE. Curr Protein Pept Sci (2011) 0.84
MBL2 functional allelic variants and increased risk for the development of atopic dermatitis in Brazilian children. Arch Dermatol (2008) 0.83
MBL2 gene polymorphisms are correlated with high-risk human papillomavirus infection but not with human papillomavirus-related cervical cancer. Hum Immunol (2009) 0.83
Asbestos and SV40 in malignant pleural mesothelioma from a hyperendemic area of north-eastern Italy. Tumori (2012) 0.83
Clinical genetic testing of periodic fever syndromes. Biomed Res Int (2013) 0.83
Systemic and neuronal inflammatory markers in a mouse model of mevalonate kinase deficiency: a strain-comparative study. In Vivo (2013) 0.82
Prognostic value of the stromal cell-derived factor 1 3'A mutation in pediatric human immunodeficiency virus type 1 infection. J Infect Dis (2002) 0.82
Association of polymorphisms in the first exon of mannose binding lectin gene (MBL2) in Brazilian patients with HCV infection. Clin Immunol (2007) 0.82
Phospholipase C-β3 is a key modulator of IL-8 expression in cystic fibrosis bronchial epithelial cells. J Immunol (2011) 0.82
Variant mannose-binding lectin alleles are associated with celiac disease. Immunogenetics (2002) 0.82
Ear nose throat manifestations in hypoidrotic ectodermal dysplasia. Int J Pediatr Otorhinolaryngol (2013) 0.82
MBL2 polymorphisms are involved in HIV-1 infection in Brazilian perinatally infected children. AIDS (2003) 0.82
Differential expression of genes at stages when regeneration can and cannot occur after injury to immature mammalian spinal cord. Cell Mol Neurobiol (2005) 0.82
Role of DC-SIGN and L-SIGN receptors in HIV-1 vertical transmission. Hum Immunol (2011) 0.81
Inflammation profile of four early onset Crohn patients. Gene (2011) 0.81
Beta defensin-1 gene polymorphisms and susceptibility to atypical squamous cells of undetermined significance lesions in Italian gynecological patients. J Med Virol (2014) 0.81
MBL2 genetic screening in patients with recurrent vaginal infections. Am J Reprod Immunol (2008) 0.81
Ethnobotanical bioprospection of candidates for potential antimicrobial drugs from Brazilian plants: state of art and perspectives. Curr Protein Pept Sci (2010) 0.81
GRID2 a novel gene possibly associated with mevalonate kinase deficiency. Rheumatol Int (2014) 0.81
Interleukin 18 (IL18) gene promoter polymorphisms are associated with type 1 diabetes mellitus in Brazilian patients. Cytokine (2013) 0.80
Novel E6 and E7 oncogenes variants of human papillomavirus type 31 in Brazilian women with abnormal cervical cytology. Infect Genet Evol (2013) 0.80
Phylogenetic relationships among the Lorisoidea as indicated by craniodental morphology and mitochondrial sequence data. Am J Primatol (2007) 0.80
TRAIL administration down-modulated the acute systemic inflammatory response induced in a mouse model by muramyldipeptide or lipopolysaccharide. Cytokine (2012) 0.80
Synergy between mannose-binding lectin gene polymorphisms and supplementation with vitamin A influences susceptibility to HIV infection in infants born to HIV-positive mothers. Am J Clin Nutr (2006) 0.80
Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders. J Neurovirol (2012) 0.80
Glutathione S-transferase homozygous deletions and relapse in childhood acute lymphoblastic leukemia: a novel study design in a large Italian AIEOP cohort. Pharmacogenomics (2012) 0.80
Lack of association between Interleukin-18 gene promoter polymorphisms and onset of Alzheimer's disease. Neurobiol Aging (2008) 0.79
Mannose binding lectin gene (MBL2) functional polymorphisms are associated with systemic lupus erythematosus in southern Brazilians. Hum Immunol (2011) 0.79
HLA-G 14 bp deletion/insertion polymorphism in celiac disease. Am J Gastroenterol (2010) 0.79
Susceptibility to Mycobacterium tuberculosis infection in HIV-positive patients is associated with CARD8 genetic variant. J Acquir Immune Defic Syndr (2013) 0.79
Extracellular NAD+: a novel autocrine/paracrine signal in osteoblast physiology. Biochem Biophys Res Commun (2002) 0.79
Frequency distribution of HLA DQ2 and DQ8 in celiac patients and first-degree relatives in Recife, northeastern Brazil. Clinics (Sao Paulo) (2011) 0.79
The effect of clodronate on a mevalonate kinase deficiency cellular model. Inflamm Res (2012) 0.79
Complement factor H gene (CFH) polymorphisms C-257T, G257A and haplotypes are associated with protection against severe dengue phenotype, possible related with high CFH expression. Hum Immunol (2013) 0.79